83 FR 17678 - Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 83, Issue 78 (April 23, 2018)
Drug Enforcement Administration
Federal Register Volume 83, Issue 78 (April 23, 2018)
| Page Range | 17678-17681 | |
| FR Document | 2018-08348 |
[Federal Register Volume 83, Number 78 (Monday, April 23, 2018)] [Notices] [Pages 17678-17681] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-08348] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before June 22, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on March 8, 2018, Cayman Chemical Company, 1180 East Ellsworth Road, Ann Arbor, Michigan 48108 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: ------------------------------------------------------------------------ Controlled substance Drug code Schedule ------------------------------------------------------------------------ 3-Fluoro-N-methylcathinone (3-FMC)...... 1233 I Cathinone............................... 1235 I Methcathinone........................... 1237 I 4-Fluoro-N-methylcathinone (4-FMC)...... 1238 I Pentedrone ([alpha]- 1246 I methylaminovalerophenone).............. Mephedrone (4-Methyl-N-methylcathinone). 1248 I 4-Methyl-N-ethylcathinone (4-MEC)....... 1249 I Naphyrone............................... 1258 I N-Ethylamphetamine...................... 1475 I N,N-Dimethylamphetamine................. 1480 I Fenethylline............................ 1503 I Aminorex................................ 1585 I 4-Methylaminorex (cis isomer)........... 1590 I Gamma Hydroxybutyric Acid............... 2010 I Methaqualone............................ 2565 I Mecloqualone............................ 2572 I JWH-250 (1-Pentyl-3-(2- 6250 I methoxyphenylacetyl) indole)........... SR-18 (Also known as RCS-8) (1- 7008 I Cyclohexylethyl-3-(2- methoxyphenylacetyl) indole)........... ADB-FUBINACA (n-(1-amino-3,3-dimethyl-1- 7010 I oxobutan-2-yl)-1-(4-fluorobenzyl)-1H- indazole-3-carboxamide)................ 5-Flouro-UR-144 and XLR11 [1-(5-Fluoro- 7011 I pentyl)1H-indol-3-yl](2,2,3,3- tetramethylcyclopropyl)methanone....... AB-FUBINACA (N-(1-amino-3-methyl-1- 7012 I oxobutan-2-yl)-1-(4-fluorobenzyl)-1H- indazole-3-carboxamide)................ JWH-019 (1-Hexyl-3-(1-naphthoyl)indole). 7019 I MDMB-FUBINACA (Methyl 2-(1-4- 7020 I fluorobenzyl)-1H-indazole-3- carboxamido)-3,3-dimethylbutanoate).... 2-(1-(4-fluorobenzyl)-1Hindazole-3- 7021 I carboxamido)-3- methylbutanoate........ AB-PINACA (N-(1-amino-3-methyl-......... 7023 I 1-oxobutan-2-yl)-1-pentyl-1H-indazole-.. 3-carboxamide).......................... THJ-2201 [1-(5-fluoropentyl)-1H-indazol- 7024 I 3-..................................... yl](naphthalen-1-yl)methanone........... AB-CHMINACA (N-(1-amino-3-methyl-1-..... 7031 I oxobutan-2-yl)-1-(cyclohexylmethyl)-.... 1H-indazole-3-carboxamide............... MAB-CHMINACA (N-(1-amino-3,3dimethyl-1- 7032 I oxobutan-2-yl)-1-(cyclohexylmethyl)-1H- indazole-3-carboxamide)................ 5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H- 7033 I indazola-3-carboxamido)-3- methylbutanoate)....................... 5F-ADB; 5F-MDMB-PINACA (Methyl 2-(1- 7034 I (5fluoropentyl)-1H-indazole-3- carboxamido)-3,3dimethylbutanoate)..... ADB-PINACA (N-(1-amino-3,3-dimethyl-1- 7035 I oxobutan-2-yl)-1-pentyl-1H-indazole-3- carboxamide)........................... MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1- 7042 I (cyclohenxylmethyl)-1H-indole-3- carboxamido)-3,3-dimethylbutanote)-.... APINACA and AKB48 N-(1-Adamantyl)-1- 7048 I pentyl-1H-indazole-3-carboxamide....... [[Page 17679]] 5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)- 7049 I 1-(5fluoropentyl)-1H-indazole-3- carboxamide)........................... JWH-081 (1-Pentyl-3-(1-(4- 7081 I methoxynaphthoyl) indole).............. SR-19 (Also known as RCS-4) (1-Pentyl-3- 7104 I [(4-methoxy)-benzoyl] indole........... JWH-018 (also known as AM678) (1-Pentyl- 7118 I 3-(1-naphthoyl)indole)................. JWH-122 (1-Pentyl-3-(4-methyl-1- 7122 I naphthoyl) indole)..................... UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- 7144 I tetramethylcyclopropyl)methanone....... JWH-073 (1-Butyl-3-(1-naphthoyl)indole). 7173 I JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1- 7200 I naphthoyl)indole)...................... AM2201 (1-(5-Fluoropentyl)-3-(1- 7201 I naphthoyl) indole)..................... JWH-203 (1-Pentyl-3-(2- 7203 I chlorophenylacetyl) indole)............ PB-22 (Quinolin-8-yl 1-pentyl-1H-indole- 7222 I 3-carboxylate)......................... 5F-PB-22 (Quinolin-8-yl 1-(5- 7225 I fluoropentyl)-1H-indole-3-carboxylate). Alpha-ethyltryptamine................... 7249 I Ibogaine................................ 7260 I CP-47,497 (5-(1,1-Dimethylheptyl)-2- 7297 I [(1R,3S)-3-hydroxycyclohexyl-phenol)... CP-47,497 C8 Homologue (5-(1,1- 7298 I Dimethyloctyl)-2-[(1R,3S)3- hydroxycyclohexyl-phenol).............. Lysergic acid diethylamide.............. 7315 I 2,5-Dimethoxy-4-(n)- 7348 I propylthiophenethylamine (2C-T-7)...... Marihuana............................... 7360 I Tetrahydrocannabinols................... 7370 I Mescaline............................... 7381 I 2-(4-Ethylthio-2,5-dimethoxyphenyl) 7385 I ethanamine (2C-T-2 )................... 3,4,5-Trimethoxyamphetamine............. 7390 I 4-Bromo-2,5-dimethoxyamphetamine........ 7391 I 4-Bromo-2,5-dimethoxyphenethylamine..... 7392 I 4-Methyl-2,5-dimethoxyamphetamine....... 7395 I 2,5-Dimethoxyamphetamine................ 7396 I JWH-398 (1-Pentyl-3-(4-chloro-1- 7398 I naphthoyl) indole)..................... 2,5-Dimethoxy-4-ethylamphetamine........ 7399 I 3,4-Methylenedioxyamphetamine........... 7400 I 5-Methoxy-3,4-methylenedioxyamphetamine. 7401 I N-Hydroxy-3,4-methylenedioxyamphetamine. 7402 I 3,4-Methylenedioxy-N-ethylamphetamine... 7404 I 3,4-Methylenedioxymethamphetamine....... 7405 I 4-Methoxyamphetamine.................... 7411 I 5-Methoxy-N-N-dimethyltryptamine........ 7431 I Alpha-methyltryptamine.................. 7432 I Diethyltryptamine....................... 7434 I Dimethyltryptamine...................... 7435 I Psilocybin.............................. 7437 I Psilocyn................................ 7438 I 5-Methoxy-N,N-diisopropyltryptamine..... 7439 I N-Ethyl-1-phenylcyclohexylamine......... 7455 I 1-(1-Phenylcyclohexyl)pyrrolidine....... 7458 I 1-[1-(2-Thienyl)cyclohexyl]piperidine... 7470 I 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine.. 7473 I N-Benzylpiperazine...................... 7493 I 2-(2,5-Dimethoxy-4-methylphenyl) 7508 I ethanamine (2C-D)...................... 2-(2,5-Dimethoxy-4-ethylphenyl) 7509 I ethanamine (2C-E )..................... 2-(2,5-Dimethoxyphenyl) ethanamine (2C- 7517 I H)..................................... 2-(4-iodo-2,5-dimethoxyphenyl) 7518 I ethanamine (2C-I)...................... 2-(4-Chloro-2,5-dimethoxyphenyl) 7519 I ethanamine (2C-C)...................... 2-(2,5-Dimethoxy-4-nitro-phenyl) 7521 I ethanamine (2C-N)...................... 2-(2,5-Dimethoxy-4-(n)-propylphenyl) 7524 I ethanamine (2C-P)...................... 2-(4-Isopropylthio)-2,5-dimethoxyphenyl) 7532 I ethanamine (2C-T-4 )................... MDPV (3,4-Methylenedioxypyrovalerone)... 7535 I 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2- 7536 I methoxybenzyl) ethanamine (25B-NBOMe).. 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2- 7537 I methoxybenzyl)......................... ethanamine (25C-NBOMe).................. 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2- 7538 I methoxybenzyl) ethanamine (25I-NBOMe).. Methylone (3,4-Methylenedioxy-N- 7540 I methylcathinone)....................... Butylone................................ 7541 I Pentylone............................... 7542 I alpha-pyrrolidinopentiophenone ([alpha]- 7545 I PVP)................................... alpha-pyrrolidinobutiophenone ([alpha]- 7546 I PBP)................................... AM-694 (1-(5-Fluoropentyl)-3-(2- 7694 I iodobenzoyl) indole)................... Acetyldihydrocodeine.................... 9051 I Benzylmorphine.......................... 9052 I Codeine-N-oxide......................... 9053 I Desomorphine............................ 9055 I Etorphine (except HCl).................. 9056 I Codeine methylbromide................... 9070 I Dihydromorphine......................... 9145 I Heroin.................................. 9200 I [[Page 17680]] Morphine-N-oxide........................ 9307 I Normorphine............................. 9313 I U-47700 (3,4-dichloro-N-[2- 9547 I (dimethylamino)cyclohexyl]-N- methylbenzamide)....................... MT-45 (1-cyclohexyl-4-(1,2- 9560 I diphenylethyl)piperazine))............. Tilidine................................ 9750 I Acryl fentanyl (N-(1-phenethylpiperidin- 9811 I 4-yl)-N-phenylacrylamide).............. Para-Fluorofentanyl..................... 9812 I 3-Methylfentanyl........................ 9813 I Alpha-methylfentanyl.................... 9814 I Acetyl-alpha-methylfentanyl............. 9815 I N-(2-fluorophenyl)-N-(1- 9816 I phenethylpiperidin-4-yl)propionamide... Acetyl Fentanyl (N-(1-phenethylpiperidin- 9821 I 4-yl)-N-phenylacetamide)............... Butyryl Fentanyl........................ 9822 I Para-fluorobutyryl fentanyl............. 9823 I 4-Fluoroisobutyryl fentanyl (N-(4- 9824 I fluorophenyl)-N-(1phenethylpiperidin-4- yl)isobutyramide)...................... 2-methoxy-N-(1-phenethylpiperidin-4-yl)- 9825 I N-phenylacetamide...................... Para-chloroisobutyryl fentanyl.......... 9826 I Isobutyryl fentanyl..................... 9827 I Beta-hydroxyfentanyl.................... 9830 I Beta-hydroxy-3-methylfentanyl........... 9831 I Alpha-methylthiofentanyl................ 9832 I 3-Methylthiofentanyl.................... 9833 I Furanyl fentanyl (N-(1- 9834 I phenethylpiperidin-4-yl)-N-phenylfuran- 2-carboxamide)......................... Thiofentanyl............................ 9835 I Beta-hydroxythiofentanyl................ 9836 I Para-methoxybutyryl fentanyl............ 9837 I Ocfentanil.............................. 9838 I Valeryl fentanyl........................ 9840 I N-(1-phenethylpiperidin-4-yl)-N- 9843 I phenyltetrahydrofuran-2-carboxamide.... Cyclopropyl Fentanyl.................... 9845 I Cyclopentyl fentanyl.................... 9847 I Fentanyl related-compounds as defined in 9850 I 21 CFR 1308.11(h)...................... Amphetamine............................. 1100 II Methamphetamine......................... 1105 II Lisdexamfetamine........................ 1205 II Phenmetrazine........................... 1631 II Methylphenidate......................... 1724 II Amobarbital............................. 2125 II Pentobarbital........................... 2270 II Secobarbital............................ 2315 II Phencyclidine........................... 7471 II 4-Anilino-N-phenethyl-4-piperidine 8333 II (ANPP)................................. Phenylacetone........................... 8501 II 1-Piperidinocyclohexanecarbonitrile..... 8603 II Cocaine................................. 9041 II Codeine................................. 9050 II Etorphine HCl........................... 9059 II Dihydrocodeine.......................... 9120 II Oxycodone............................... 9143 II Hydromorphone........................... 9150 II Ecgonine................................ 9180 II Ethylmorphine........................... 9190 II Hydrocodone............................. 9193 II Levomethorphan.......................... 9210 II Levorphanol............................. 9220 II Isomethadone............................ 9226 II Meperidine.............................. 9230 II Meperidine intermediate-B............... 9233 II Methadone............................... 9250 II Dextropropoxyphene, bulk (non-dosage 9273 II forms)................................. Morphine................................ 9300 II Thebaine................................ 9333 II Oxymorphone............................. 9652 II Thiafentanil............................ 9729 II Alfentanil.............................. 9737 II Remifentanil............................ 9739 II Sufentanil.............................. 9740 II Carfentanil............................. 9743 II Tapentadol.............................. 9780 II Fentanyl................................ 9801 II ------------------------------------------------------------------------ [[Page 17681]] The company plans to manufacture bulk controlled substances for use in product development of analytical reference standards for distribution to its customers. The company will manufacture marihuana (7360) and tetrahydrocannabinols (7370) for use by their researchers under the above-listed controlled substances as Active Pharmaceutical Ingredient (API) for clinical trials. In reference to drug code (7370) the company plans to bulk manufacture a synthetic tetrahydrocannabinol. No other activities for this drug code are authorized for this registration. Dated: April 13, 2018. Susan A. Gibson, Deputy Assistant Administrator. [FR Doc. 2018-08348 Filed 4-20-18; 8:45 am] BILLING CODE 4410-09-P
![17678 Federal Register / Vol. 83, No. 78 / Monday, April 23, 2018 / Notices
that Nokia Solutions and Networks US Practice and Procedure (19 CFR part Register Representative/DRW, 8701
LLC no longer exists as of January 1, 210). Morrissette Drive, Springfield, Virginia
2018. Based on this stipulation, By order of the Commission. 22152.
complainants agreed to withdraw the Issued: April 17, 2018. SUPPLEMENTARY INFORMATION: The
complaint as to Nokia Solutions and Lisa Barton, Attorney General has delegated his
Networks B.V., Nokia Solutions and Secretary to the Commission. authority under the Controlled
Networks Oy, and Nokia Solutions and Substances Act to the Administrator of
[FR Doc. 2018–08369 Filed 4–20–18; 8:45 am]
Networks US LLC. the Drug Enforcement Administration
BILLING CODE 7020–02–P
On March 19, 2018, the ALJ issued (DEA), 28 CFR 0.100(b). Authority to
the subject ID granting complainants’ exercise all necessary functions with
motion. The ALJ found that good cause DEPARTMENT OF JUSTICE respect to the promulgation and
exists to amend the complaint and there implementation of 21 CFR part 1301,
is no evidence of any prejudice to the Drug Enforcement Administration incident to the registration of
parties in the investigation. The ALJ manufacturers, distributors, dispensers,
[Docket No. DEA–392]
found that no extraordinary importers, and exporters of controlled
circumstances prevent the partial Bulk Manufacturer of Controlled substances (other than final orders in
termination of the investigation as to Substances Application: Cayman connection with suspension, denial, or
Nokia Solutions and Networks B.V., Chemical Company revocation of registration) has been
Nokia Solutions and Networks Oy, and redelegated to the Assistant
Nokia Solutions and Networks US LLC. ACTION: Notice of application. Administrator of the DEA Diversion
None of the parties petitioned for review Control Division (‘‘Assistant
of the subject ID. DATES: Registered bulk manufacturers of Administrator’’) pursuant to section 7 of
the affected basic classes, and 28 CFR part 0, appendix to subpart R.
The Commission has determined not applicants therefore, may file written In accordance with 21 CFR
to review the ID. comments on or objections to the 1301.33(a), this is notice that on March
The authority for the Commission’s issuance of the proposed registration on 8, 2018, Cayman Chemical Company,
determination is contained in section or before June 22, 2018. 1180 East Ellsworth Road, Ann Arbor,
337 of the Tariff Act of 1930, as ADDRESSES: Written comments should Michigan 48108 applied to be registered
amended (19 U.S.C. 1337), and in Part be sent to: Drug Enforcement as a bulk manufacturer of the following
210 of the Commission’s Rules of Administration, Attention: DEA Federal basic classes of controlled substances:
Controlled substance Drug code Schedule
3-Fluoro-N-methylcathinone (3–FMC) ..................................................................................................................... 1233 I
Cathinone ................................................................................................................................................................. 1235 I
Methcathinone ......................................................................................................................................................... 1237 I
4-Fluoro-N-methylcathinone (4–FMC) ..................................................................................................................... 1238 I
Pentedrone (a-methylaminovalerophenone) ........................................................................................................... 1246 I
Mephedrone (4-Methyl-N-methylcathinone) ............................................................................................................ 1248 I
4-Methyl-N-ethylcathinone (4–MEC) ....................................................................................................................... 1249 I
Naphyrone ............................................................................................................................................................... 1258 I
N-Ethylamphetamine ............................................................................................................................................... 1475 I
N,N-Dimethylamphetamine ...................................................................................................................................... 1480 I
Fenethylline .............................................................................................................................................................. 1503 I
Aminorex .................................................................................................................................................................. 1585 I
4-Methylaminorex (cis isomer) ................................................................................................................................ 1590 I
Gamma Hydroxybutyric Acid ................................................................................................................................... 2010 I
Methaqualone .......................................................................................................................................................... 2565 I
Mecloqualone ........................................................................................................................................................... 2572 I
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) .......................................................................................... 6250 I
SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ........................................ 7008 I
ADB–FUBINACA (n-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ..... 7010 I
5-Flouro-UR–144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ........ 7011 I
AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ............. 7012 I
JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) .............................................................................................................. 7019 I
MDMB–FUBINACA (Methyl 2-(1-4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ................ 7020 I
2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3- methylbutanoate ................................................................... 7021 I
AB–PINACA (N-(1-amino-3-methyl- ........................................................................................................................
1-oxobutan-2-yl)-1-pentyl-1H-indazole- ...................................................................................................................
3-carboxamide) ........................................................................................................................................................ 7023 I
THJ–2201 [1-(5-fluoropentyl)-1H-indazol-3- ............................................................................................................
yl](naphthalen-1-yl)methanone ................................................................................................................................ 7024 I
AB–CHMINACA (N-(1-amino-3-methyl-1- ...............................................................................................................
oxobutan-2-yl)-1-(cyclohexylmethyl)- .......................................................................................................................
1H-indazole-3-carboxamide ..................................................................................................................................... 7031 I
amozie on DSK30RV082PROD with NOTICES
MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) 7032 I
5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazola-3-carboxamido)-3-methylbutanoate) ...................................... 7033 I
5F–ADB; 5F–MDMB–PINACA (Methyl 2-(1-(5fluoropentyl)-1H-indazole-3-carboxamido)-3,3dimethylbutanoate) 7034 I
ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ......................... 7035 I
MDMB–CHMICA, MMB–CHMINACA (Methyl 2-(1-(cyclohenxylmethyl)-1H-indole-3-carboxamido)-3,3-
dimethylbutanote)- ................................................................................................................................................ 7042 I
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide ....................................................... 7048 I
VerDate Sep<11>2014 17:09 Apr 20, 2018 Jkt 244001 PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 E:\FR\FM\23APN1.SGM 23APN1](https://thefederalregister.org/doc/83_FR_17756/page/1.svg)
![Federal Register / Vol. 83, No. 78 / Monday, April 23, 2018 / Notices 17679
Controlled substance Drug code Schedule
5F–APINACA, 5F–AKB48 (N-(adamantan-1-yl)-1-(5fluoropentyl)-1H-indazole-3-carboxamide) ............................ 7049 I
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) .......................................................................................... 7081 I
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole ............................................................ 7104 I
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ...................................................................... 7118 I
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ............................................................................................. 7122 I
UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ......................................................... 7144 I
JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ............................................................................................................... 7173 I
JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) .................................................................................. 7200 I
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ............................................................................................... 7201 I
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) .............................................................................................. 7203 I
PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ......................................................................................... 7222 I
5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) .................................................................... 7225 I
Alpha-ethyltryptamine .............................................................................................................................................. 7249 I
Ibogaine ................................................................................................................................................................... 7260 I
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ......................................................... 7297 I
CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ................................... 7298 I
Lysergic acid diethylamide ...................................................................................................................................... 7315 I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) ...................................................................................... 7348 I
Marihuana ................................................................................................................................................................ 7360 I
Tetrahydrocannabinols ............................................................................................................................................ 7370 I
Mescaline ................................................................................................................................................................. 7381 I
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C–T–2 ) .................................................................................. 7385 I
3,4,5-Trimethoxyamphetamine ................................................................................................................................ 7390 I
4-Bromo-2,5-dimethoxyamphetamine ...................................................................................................................... 7391 I
4-Bromo-2,5-dimethoxyphenethylamine .................................................................................................................. 7392 I
4-Methyl-2,5-dimethoxyamphetamine ...................................................................................................................... 7395 I
2,5-Dimethoxyamphetamine .................................................................................................................................... 7396 I
JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) .............................................................................................. 7398 I
2,5-Dimethoxy-4-ethylamphetamine ........................................................................................................................ 7399 I
3,4-Methylenedioxyamphetamine ............................................................................................................................ 7400 I
5-Methoxy-3,4-methylenedioxyamphetamine .......................................................................................................... 7401 I
N-Hydroxy-3,4-methylenedioxyamphetamine .......................................................................................................... 7402 I
3,4-Methylenedioxy-N-ethylamphetamine ............................................................................................................... 7404 I
3,4-Methylenedioxymethamphetamine .................................................................................................................... 7405 I
4-Methoxyamphetamine .......................................................................................................................................... 7411 I
5-Methoxy-N-N-dimethyltryptamine ......................................................................................................................... 7431 I
Alpha-methyltryptamine ........................................................................................................................................... 7432 I
Diethyltryptamine ..................................................................................................................................................... 7434 I
Dimethyltryptamine .................................................................................................................................................. 7435 I
Psilocybin ................................................................................................................................................................. 7437 I
Psilocyn .................................................................................................................................................................... 7438 I
5-Methoxy-N,N-diisopropyltryptamine ...................................................................................................................... 7439 I
N-Ethyl-1-phenylcyclohexylamine ............................................................................................................................ 7455 I
1-(1-Phenylcyclohexyl)pyrrolidine ............................................................................................................................ 7458 I
1-[1-(2-Thienyl)cyclohexyl]piperidine ....................................................................................................................... 7470 I
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine ...................................................................................................................... 7473 I
N-Benzylpiperazine .................................................................................................................................................. 7493 I
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C–D) .......................................................................................... 7508 I
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C–E ) ............................................................................................ 7509 I
2-(2,5-Dimethoxyphenyl) ethanamine (2C–H) ......................................................................................................... 7517 I
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C–I) ................................................................................................ 7518 I
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C–C) .......................................................................................... 7519 I
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C–N) ............................................................................................ 7521 I
2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C–P) ..................................................................................... 7524 I
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C–T–4 ) ........................................................................... 7532 I
MDPV (3,4-Methylenedioxypyrovalerone) ............................................................................................................... 7535 I
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B–NBOMe) ............................................ 7536 I
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) .........................................................................................
ethanamine (25C–NBOMe) ..................................................................................................................................... 7537 I
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I–NBOMe) ................................................. 7538 I
Methylone (3,4-Methylenedioxy-N-methylcathinone) .............................................................................................. 7540 I
Butylone ................................................................................................................................................................... 7541 I
Pentylone ................................................................................................................................................................. 7542 I
alpha-pyrrolidinopentiophenone (a-PVP) ................................................................................................................ 7545 I
alpha-pyrrolidinobutiophenone (a-PBP) .................................................................................................................. 7546 I
AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ........................................................................................... 7694 I
Acetyldihydrocodeine ............................................................................................................................................... 9051 I
amozie on DSK30RV082PROD with NOTICES
Benzylmorphine ....................................................................................................................................................... 9052 I
Codeine-N-oxide ...................................................................................................................................................... 9053 I
Desomorphine .......................................................................................................................................................... 9055 I
Etorphine (except HCl) ............................................................................................................................................ 9056 I
Codeine methylbromide ........................................................................................................................................... 9070 I
Dihydromorphine ...................................................................................................................................................... 9145 I
Heroin ...................................................................................................................................................................... 9200 I
VerDate Sep<11>2014 17:09 Apr 20, 2018 Jkt 244001 PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 E:\FR\FM\23APN1.SGM 23APN1](https://thefederalregister.org/doc/83_FR_17756/page/2.svg)
![17680 Federal Register / Vol. 83, No. 78 / Monday, April 23, 2018 / Notices
Controlled substance Drug code Schedule
Morphine-N-oxide .................................................................................................................................................... 9307 I
Normorphine ............................................................................................................................................................ 9313 I
U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ...................................................... 9547 I
MT–45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) ........................................................................................... 9560 I
Tilidine ...................................................................................................................................................................... 9750 I
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) ......................................................................... 9811 I
Para-Fluorofentanyl ................................................................................................................................................. 9812 I
3-Methylfentanyl ....................................................................................................................................................... 9813 I
Alpha-methylfentanyl ............................................................................................................................................... 9814 I
Acetyl-alpha-methylfentanyl ..................................................................................................................................... 9815 I
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide ............................................................................... 9816 I
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ....................................................................... 9821 I
Butyryl Fentanyl ....................................................................................................................................................... 9822 I
Para-fluorobutyryl fentanyl ....................................................................................................................................... 9823 I
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1phenethylpiperidin-4-yl)isobutyramide) .................................. 9824 I
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide ................................................................................. 9825 I
Para-chloroisobutyryl fentanyl ................................................................................................................................. 9826 I
Isobutyryl fentanyl .................................................................................................................................................... 9827 I
Beta-hydroxyfentanyl ............................................................................................................................................... 9830 I
Beta-hydroxy-3-methylfentanyl ................................................................................................................................ 9831 I
Alpha-methylthiofentanyl .......................................................................................................................................... 9832 I
3-Methylthiofentanyl ................................................................................................................................................. 9833 I
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) ..................................................... 9834 I
Thiofentanyl ............................................................................................................................................................. 9835 I
Beta-hydroxythiofentanyl ......................................................................................................................................... 9836 I
Para-methoxybutyryl fentanyl .................................................................................................................................. 9837 I
Ocfentanil ................................................................................................................................................................. 9838 I
Valeryl fentanyl ........................................................................................................................................................ 9840 I
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide .................................................................. 9843 I
Cyclopropyl Fentanyl ............................................................................................................................................... 9845 I
Cyclopentyl fentanyl ................................................................................................................................................. 9847 I
Fentanyl related-compounds as defined in 21 CFR 1308.11(h) ............................................................................. 9850 I
Amphetamine ........................................................................................................................................................... 1100 II
Methamphetamine ................................................................................................................................................... 1105 II
Lisdexamfetamine .................................................................................................................................................... 1205 II
Phenmetrazine ......................................................................................................................................................... 1631 II
Methylphenidate ....................................................................................................................................................... 1724 II
Amobarbital .............................................................................................................................................................. 2125 II
Pentobarbital ............................................................................................................................................................ 2270 II
Secobarbital ............................................................................................................................................................. 2315 II
Phencyclidine ........................................................................................................................................................... 7471 II
4-Anilino-N-phenethyl-4-piperidine (ANPP) ............................................................................................................. 8333 II
Phenylacetone ......................................................................................................................................................... 8501 II
1-Piperidinocyclohexanecarbonitrile ........................................................................................................................ 8603 II
Cocaine .................................................................................................................................................................... 9041 II
Codeine .................................................................................................................................................................... 9050 II
Etorphine HCl .......................................................................................................................................................... 9059 II
Dihydrocodeine ........................................................................................................................................................ 9120 II
Oxycodone ............................................................................................................................................................... 9143 II
Hydromorphone ....................................................................................................................................................... 9150 II
Ecgonine .................................................................................................................................................................. 9180 II
Ethylmorphine .......................................................................................................................................................... 9190 II
Hydrocodone ............................................................................................................................................................ 9193 II
Levomethorphan ...................................................................................................................................................... 9210 II
Levorphanol ............................................................................................................................................................. 9220 II
Isomethadone .......................................................................................................................................................... 9226 II
Meperidine ............................................................................................................................................................... 9230 II
Meperidine intermediate-B ....................................................................................................................................... 9233 II
Methadone ............................................................................................................................................................... 9250 II
Dextropropoxyphene, bulk (non-dosage forms) ...................................................................................................... 9273 II
Morphine .................................................................................................................................................................. 9300 II
Thebaine .................................................................................................................................................................. 9333 II
Oxymorphone .......................................................................................................................................................... 9652 II
amozie on DSK30RV082PROD with NOTICES
Thiafentanil .............................................................................................................................................................. 9729 II
Alfentanil .................................................................................................................................................................. 9737 II
Remifentanil ............................................................................................................................................................. 9739 II
Sufentanil ................................................................................................................................................................. 9740 II
Carfentanil ................................................................................................................................................................ 9743 II
Tapentadol ............................................................................................................................................................... 9780 II
Fentanyl ................................................................................................................................................................... 9801 II
VerDate Sep<11>2014 17:09 Apr 20, 2018 Jkt 244001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\23APN1.SGM 23APN1](https://thefederalregister.org/doc/83_FR_17756/page/3.svg)
![Federal Register / Vol. 83, No. 78 / Monday, April 23, 2018 / Notices 17681
The company plans to manufacture proof of delivery from another delivery (3) Other hand-held drill equipment
bulk controlled substances for use in service such as UPS or Federal Express may be used if approved in advance by
product development of analytical on or before the deadline for comments. the MSHA District Manager.
reference standards for distribution to FOR FURTHER INFORMATION CONTACT: (4) All nonpermissible low-voltage or
its customers. Barbara Barron, Office of Standards, battery-powered nonpermissible hand-
The company will manufacture Regulations, and Variances at 202–693– held equipment to be used in or inby
marihuana (7360) and 9447 (Voice), barron.barbara@dol.gov the last open crosscut will be examined
tetrahydrocannabinols (7370) for use by (email), or 202–693–9441 (Facsimile). prior to use by a certified person to
their researchers under the above-listed [These are not toll-free numbers.] ensure the equipment is being
controlled substances as Active maintained in a safe operating
SUPPLEMENTARY INFORMATION: Section
Pharmaceutical Ingredient (API) for condition.
clinical trials. 101(c) of the Federal Mine Safety and
(5) The results of the examinations
In reference to drug code (7370) the Health Act of 1977 and Title 30 of the
will be recorded and retained for one
company plans to bulk manufacture a Code of Federal Regulations Part 44
year and made available to MSHA on
synthetic tetrahydrocannabinol. No govern the application, processing, and
request.
other activities for this drug code are disposition of petitions for modification. (6) A qualified person, as defined in
authorized for this registration. I. Background 30 CFR 75.151, will continuously
Dated: April 13, 2018. monitor for methane immediately before
Section 101(c) of the Federal Mine
Susan A. Gibson, and during the use of nonpermissible
Safety and Health Act of 1977 (Mine
Deputy Assistant Administrator.
hand-held drill equipment in or inby
Act) allows the mine operator or
the last open crosscut.
[FR Doc. 2018–08348 Filed 4–20–18; 8:45 am] representative of miners to file a (7) Nonpermissible hand-held drill
BILLING CODE 4410–09–P petition to modify the application of any equipment will not be used if methane
mandatory safety standard to a coal or is detected in concentrations at or above
other mine if the Secretary of Labor 1.0 percent. When methane is detected
DEPARTMENT OF LABOR (Secretary) determines that: at such level while the nonpermissible
1. An alternative method of achieving hand-held drill equipment is being
Mine Safety and Health Administration the result of such standard exists which used, the equipment will be deenergized
will at all times guarantee no less than immediately and withdrawn outby the
Petitions for Modification of the same measure of protection afforded
Application of Existing Mandatory last open crosscut.
the miners of such mine by such (8) All hand-held methane detectors
Safety Standards standard; or will be MSHA-approved and
AGENCY: Mine Safety and Health 2. That the application of such maintained in permissible and proper
Administration, Labor. standard to such mine will result in a operating condition as defined in 30
ACTION: Notice. diminution of safety to the miners in CFR 75.320.
such mine. (9) Coal production will cease in the
SUMMARY: This notice is a summary of In addition, the regulations at 30 CFR entry or crosscut where the
petitions for modification submitted to 44.10 and 44.11 establish the nonpermissible hand-held drill
the Mine Safety and Health requirements and procedures for filing equipment is in use. Accumulations of
Administration (MSHA) by the parties petitions for modification. coal and combustible materials
listed below. referenced in 30 CFR 75.400 will be
II. Petitions for Modification
DATES: All comments on the petitions removed before drilling begins to
must be received by MSHA’s Office of Docket Number: M–2018–006–C. provide additional safety to miners.
Standards, Regulations, and Variances Petitioner: Wolf Run Mining LLC, (10) Nonpermissible electronic hand-
on or before May 23, 2018. 21550 Barbour County Highway, held drill equipment will not be used
ADDRESSES: You may submit your Philippi, West Virginia 26416. when float coal dust is in suspension.
comments, identified by ‘‘docket Mine: Sentinel Mine, MSHA I.D. No. (11) All hand-held drill equipment
number’’ on the subject line, by any of 46–04168, located in Barbour County, will be used in accordance with the
the following methods: West Virginia. manufacturer’s recommended safe use
1. Electronic Mail: zzMSHA- Regulation Affected: 30 CFR 75.500(d) procedures.
comments@dol.gov. Include docket (Permissible electric equipment). (12) Qualified personnel who use
number of the petition in the subject Modification Request: The petitioner nonpermissible hand-held drill
line of the message. requests a modification of the existing equipment will be properly trained to
2. Facsimile: 202–693–9441. standard to permit an alternative recognize the hazards and limitations
3. Regular Mail or Hand Delivery: method of compliance to allow the use associated with use of such equipment
MSHA, Office of Standards, of nonpermissible electronic low- in areas where methane could be
Regulations, and Variances, 201 12th voltage or battery-powered present.
Street South, Suite 4E401, Arlington, nonpermissible electronic hand-held (13) The nonpermissible electronic
Virginia 22202–5452, Attention: Sheila drill equipment in or inby the last open hand-held drill equipment will not be
McConnell, Director, Office of crosscut. put into service until MSHA has
Standards, Regulations, and Variances. The petitioner states that: initially inspected the equipment and
Persons delivering documents are (1) Nonpermissible electronic low- determined that it is in compliance with
amozie on DSK30RV082PROD with NOTICES
required to check in at the receptionist’s voltage or battery-powered all of the above terms and conditions.
desk in Suite 4E401. Individuals may nonpermissible electronic equipment (14) Cables supplying power to low-
inspect copies of the petition and will be limited to hand-held drill voltage hand-held drill equipment will
comments during normal business equipment. only be used when permissible hand-
hours at the address listed above. (2) All other hand-held drill held drill equipment is not available.
MSHA will consider only comments equipment used in or inby the last open Within 60 days after the Proposed
postmarked by the U.S. Postal Service or crosscut will be permissible. Decision and Order (PDO) becomes
VerDate Sep<11>2014 17:09 Apr 20, 2018 Jkt 244001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 E:\FR\FM\23APN1.SGM 23APN1](https://thefederalregister.org/doc/83_FR_17756/page/4.svg)
Document Created: 2018-04-21 00:33:24
Document Modified: 2018-04-21 00:33:24
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before June 22, 2018. | |
| FR Citation | 83 FR 17678 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR